Cargando…

Sofosbuvir: A Potential Treatment for Ebola

Detalles Bibliográficos
Autores principales:	Reznik, Sandra E., Tiwari, Amit K., Ashby, Charles R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192451/ https://www.ncbi.nlm.nih.gov/pubmed/30364245 http://dx.doi.org/10.3389/fphar.2018.01139

Ejemplares similares

Potential Use of Sofosbuvir in the Prophylaxis for Rabies
por: Reznik, Sandra E., et al.
Publicado: (2020)

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?
por: Reznik, Sandra E., et al.
Publicado: (2020)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022)

Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease
por: Alasmari, Fawaz, et al.
Publicado: (2018)

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
por: Mushtaq, Saima, et al.
Publicado: (2020)

Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
por: Hendricks, Katherine, et al.
Publicado: (2020)

The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis
por: Hung, Hsuan-Yu, et al.
Publicado: (2023)

HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies
por: Amawi, Haneen, et al.
Publicado: (2017)

Sofosbuvir as a potential option for the treatment of COVID-19
por: Nourian, Anahid, et al.
Publicado: (2020)

Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis
por: Amawi, Haneen, et al.
Publicado: (2018)

Sphingosine Kinase: A Novel Putative Target for the Prevention of Infection-Triggered Preterm Birth
por: Vyas, Vibhuti, et al.
Publicado: (2013)

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir
por: Katiyar, Harshita, et al.
Publicado: (2023)

Ebanga™: The most recent FDA-approved drug for treating Ebola
por: Taki, Elahe, et al.
Publicado: (2023)

Darovasertib, a novel treatment for metastatic uveal melanoma
por: Cao, Lei, et al.
Publicado: (2023)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Sofosbuvir and daclatasvir
por: Hessel, Marleen H. M., et al.
Publicado: (2016)

Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases
por: Kosuru, Ramoji, et al.
Publicado: (2023)

Sofosbuvir for COVID-19 infection: A potential candidate
por: Gupta, Rohit, et al.
Publicado: (2020)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer
por: Balch, Curt, et al.
Publicado: (2017)

Sofosbuvir, a Significant Paradigm Change in HCV Treatment
por: McQuaid, Thomas, et al.
Publicado: (2015)

Potential clinical treatment for Ebola pandemic
por: Zhong, Ying, et al.
Publicado: (2014)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
por: Leleu, H, et al.
Publicado: (2015)

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
por: Childs-Kean, Lindsey M, et al.
Publicado: (2019)

Metacaspases: Potential Drug Target Against Protozoan Parasites
por: Vandana,, et al.
Publicado: (2019)

The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014)

Curcumin as a Potential Treatment for COVID-19
por: Rattis, Bruna A. C., et al.
Publicado: (2021)

A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
por: Shabani, M., et al.
Publicado: (2021)

Sofosbuvir‐based regimens for the treatment of chronic hepatitis C in severe renal dysfunction
por: Cox‐North, Paula, et al.
Publicado: (2017)

Cancer chemoprevention through dietary flavonoids: what’s limiting?
por: Amawi, Haneen, et al.
Publicado: (2017)

Erratum to: Cancer chemoprevention through dietary flavonoids: what’s limiting?
por: Amawi, Haneen, et al.
Publicado: (2017)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
por: Gao, Hai-Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8958us7qip114bh4bpg53qj10j